IP Library Granted Patent US 9,678,055
Granted Patent B2
US 9,678,055 · App. 14/150,322 · Granted Jun 13, 2017

Methods for forming a nanopore in a lipid bilayer

Inventors: Roger J. A. Chen (Saratoga, CA); Randy Davis (Pleasanton, CA)
Assignee: Genia Technologies, Inc.
G01N33/48721B81B1/00G01N15/12B82Y5/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,678,055
App. No.
14/150,322
Filed
Jan 8, 2014
Granted
Jun 13, 2017
Kind
B2
Art Unit
1742
USPC
264/69
Abstract

A method of forming a nanopore in a lipid bilayer is disclosed. A nanopore forming solution is deposited over a lipid bilayer. The nanopore forming solution has a concentration level and a corresponding activity level of pore molecules such that nanopores are substantially not formed un-stimulated in the lipid bilayer. Formation of a nanopore in the lipid bilayer is initiated by applying an agitation stimulus level to the lipid bilayer. In some embodiments, the concentration level and the corresponding activity level of pore molecules are at levels such that less than 30 percent of a plurality of available lipid bilayers have nanopores formed un-stimulated therein.

Claims (19)

1. A method of forming a nanopore in a lipid bilayer, comprising:

depositing a nanopore forming solution over a lipid bilayer, the nanopore forming solution having a concentration level and a corresponding activity level of pore molecules such that nanopores are substantially not formed in the lipid bilayer un-stimulated;

initiating formation of a nanopore in the lipid bilayer by a processor, comprising applying an agitation stimulus level to the lipid bilayer; and

after the agitation stimulus level, applying a measuring stimulus level to the lipid bilayer to determine that a nanopore has been formed based on a measurement in response to the measuring stimulus level, wherein an absolute magnitude of the agitation stimulus level is different from an absolute magnitude of the measuring stimulus level.

2. The method of claim 1 , wherein the concentration level and the corresponding activity level of pore molecules such that nanopores are substantially not formed in the lipid bilayer un-stimulated comprise a concentration level and a corresponding activity level of pore molecules such that approximately less than 30 percent of a plurality of lipid bilayers have nanopores formed un-stimulated.

3. The method of claim 1 , further comprising:

detecting whether a nanopore has been formed in the lipid bilayer; and

in the event that a nanopore is not detected, iteratively initiating formation of a nanopore in the lipid bilayer, comprising:

increasing the agitation stimulus level applied to the lipid bilayer; and

detecting whether a nanopore has been formed in the lipid bilayer.

4. The method of claim 3 , wherein the iteratively initiating formation of a nanopore in the lipid bilayer is repeated until formation of a nanopore is detected.

5. The method of claim 3 , wherein the iteratively initiating formation of a nanopore in the lipid bilayer is repeated until damage of the lipid bilayer is detected.

6. The method of claim 3 , wherein the iteratively initiating formation of a nanopore in the lipid bilayer is repeated until the agitation stimulus level has reached a predetermined maximum threshold.

7. The method of claim 3 , wherein the detection of whether a nanopore has been formed in the lipid bilayer comprises detecting a change in an electrical property of the lipid bilayer resulting from the formation of a nanopore in the lipid bilayer.

8. The method of claim 7 , wherein detecting a change in the lipid bilayer electrical property comprises detecting a change in a resistance of the lipid bilayer.

9. The method of claim 7 , wherein the detection of whether a nanopore has been formed in the lipid bilayer comprises determining a number of nanopores formed based on a size of change in the lipid bilayer electrical property.

10. The method of claim 9 , further comprising applying an erasing stimulus level to erase the lipid bilayer when it is determined that more than one nanopore is formed in the lipid bilayer.

11. The method of claim 1 , further comprising applying a reverse oxidation stimulus level to the lipid bilayer after the agitation stimulus level is applied.

12. The method of claim 11 , wherein the agitation stimulus level and the reverse oxidation stimulus level comprise a negative stimulus level and a positive stimulus level.

Assignments (5)
MERGER Recorded Sep 22, 2023
From: GENIA TECHNOLOGIES, INC.
To: ROCHE SEQUENCING SOLUTIONS, INC.
Reel/Frame 064999/0989 →
RELEASE OF SECURITY INTEREST Recorded Jun 3, 2014
From: GLENVIEW CAPITAL PARTNERS, L.P.; GLENVIEW OFFSHORE OPPORTUNITY MASTER FUND, LTD.; GLENVIEW CAPITAL OPPORTUNITY FUND, L.P.; GLENVIEW CAPITAL MASTER FUND, LTD.; GLENVIEW INSTITUTIONAL PARTNERS, L.P.; LIFE TECHNOLOGIES CORPORATION
To: GENIA TECHNOLOGIES, INC
Reel/Frame 033083/0170 →
RELEASE OF SECURITY INTEREST Recorded Jun 3, 2014
From: GLENVIEW CAPITAL PARTNERS, L.P.; GLENVIEW OFFSHORE OPPORTUNITY MASTER FUND, LTD; GLENVIEW CAPITAL OPPORTUNITY FUND, L.P.; GLENVIEW CAPITAL MASTER FUND, LTD.; GLENVIEW INSTITUTIONAL PARTNERS, L.P.
To: GENIA TECHNOLOGIES, INC
Reel/Frame 033083/0203 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 7, 2014
From: CHEN, ROGER J.A.; DAVIS, RANDY
To: GENIA TECHNOLOGIES, INC.
Reel/Frame 032382/0445 →
SECURITY AGREEMENT Recorded Feb 4, 2014
From: GENIA TECHNOLOGIES, INC.
To: GLENVIEW CAPITAL PARTNERS LP; GLENVIEW CAPITAL MASTER FUND LTD.; GLENVIEW INSTITUTIONAL PARTNERS, L.P.; GLENVIEW CAPITAL OPPORTUNITY FUND, LP; GLENVIEW OFFSHORE OPPORTUNITY MASTER FUND, LTD.
Reel/Frame 032161/0007 →
Continuity (2)
Continuation In Part 12658591 · Feb 8, 2010
Related Publication 20140203464A1 · Jul 24, 2014